The Centers for Medicare & Medicaid Services will introduce measures of adherence to oral hypoglycemic, antihypertensive, and cholesterol-lowering drugs into its Medicare Advantage quality program. The author discusses how, in order to achieve these adherence goals, front-line clinicians, interdisciplinary teams, organizational leaders, and policymakers will need to coordinate efforts in ways that exemplify the underlying principles of health care reform.
Topics:
antihypertensive agents, hypertension, hyperlipidemia, health care financing administration, diabetes mellitus, type 2, ...
Ann Intern Med. 2012;157(8):580-585. doi:10.7326/0003-4819-157-8-201210160-00013